PT1663240E - Combinações de um inibidor não nucleosídico da transcriptase reversa contendo pirimidina com inibidores da transcriptase eversa - Google Patents

Combinações de um inibidor não nucleosídico da transcriptase reversa contendo pirimidina com inibidores da transcriptase eversa Download PDF

Info

Publication number
PT1663240E
PT1663240E PT47870969T PT04787096T PT1663240E PT 1663240 E PT1663240 E PT 1663240E PT 47870969 T PT47870969 T PT 47870969T PT 04787096 T PT04787096 T PT 04787096T PT 1663240 E PT1663240 E PT 1663240E
Authority
PT
Portugal
Prior art keywords
inhibitors
combinations
pyrimidine containing
nnrti
containing nnrti
Prior art date
Application number
PT47870969T
Other languages
English (en)
Inventor
Paul Stoffels
Original Assignee
Janssen Sciences Ireland Uc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43778148&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1663240(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Sciences Ireland Uc filed Critical Janssen Sciences Ireland Uc
Publication of PT1663240E publication Critical patent/PT1663240E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT47870969T 2003-09-03 2004-09-03 Combinações de um inibidor não nucleosídico da transcriptase reversa contendo pirimidina com inibidores da transcriptase eversa PT1663240E (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US49977103P 2003-09-03 2003-09-03
EP03103275 2003-09-03
EP03103319 2003-09-08
EP03103335 2003-09-10
EP03103668 2003-10-02
US50848603P 2003-10-03 2003-10-03

Publications (1)

Publication Number Publication Date
PT1663240E true PT1663240E (pt) 2015-09-01

Family

ID=43778148

Family Applications (1)

Application Number Title Priority Date Filing Date
PT47870969T PT1663240E (pt) 2003-09-03 2004-09-03 Combinações de um inibidor não nucleosídico da transcriptase reversa contendo pirimidina com inibidores da transcriptase eversa

Country Status (9)

Country Link
KR (2) KR101539245B1 (pt)
CN (1) CN102319433A (pt)
DK (1) DK1663240T4 (pt)
EA (1) EA014840B1 (pt)
ES (1) ES2542017T5 (pt)
HU (1) HUE025576T2 (pt)
PT (1) PT1663240E (pt)
SI (1) SI1663240T2 (pt)
TW (1) TWI365744B (pt)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3429B1 (ar) * 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز

Also Published As

Publication number Publication date
DK1663240T3 (en) 2015-07-20
SI1663240T1 (sl) 2015-10-30
KR20110132475A (ko) 2011-12-07
ES2542017T5 (es) 2023-06-15
ES2542017T3 (es) 2015-07-29
CN102319433A (zh) 2012-01-18
TW200524612A (en) 2005-08-01
TWI365744B (en) 2012-06-11
KR101638999B1 (ko) 2016-07-12
KR101539245B1 (ko) 2015-07-27
KR20130127515A (ko) 2013-11-22
DK1663240T4 (da) 2023-04-17
EA014840B1 (ru) 2011-02-28
HUE025576T2 (en) 2016-04-28
EA200600522A1 (ru) 2006-08-25
SI1663240T2 (sl) 2023-05-31

Similar Documents

Publication Publication Date Title
HUS1600058I1 (hu) Pirimidin-tartalmú NNRTI kombinációi RT inhibitorokkal
IL175123A0 (en) Crystalline ammonium salts of rosuvastatin
AU2003251559A8 (en) Heterocyclic inhibitors of kinases
IL179743A0 (en) Pyrimidine urea derivatives as kinase inhibitors
HK1072545A1 (en) Novel inhibitors of kinases
PT1763517E (pt) Derivados de pirimidina como inibidores 11beta-hsd1
PL378116A1 (pl) Heterocykliczne inhibitory kinazy
TWI365744B (en) Combinations of a pyrimidine containing nnrti with rt inhibitors
AU153742S (en) Watch holder
ZA200609510B (en) Pyrimidine urea derivatives as kinase inhibitors
ZA200500492B (en) Novel inhibitors of kinases